BackBetter Therapeutics Overview

Better Therapeutics Other Current Liabilities

Latest other current liabilities for MCAD: $4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$4.04M
17.94% YoYΔ $-884000.00 vs prior year quarter

Peer average

Loading

Better Therapeutics Other Current Liabilities History

Loading

Better Therapeutics vs. peers: Other Current Liabilities Comparison

Loading

Better Therapeutics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Better Therapeutics (MCAD) FAQ

As of the most recent data (September 2023), MCAD shows a other current liabilities of $4M. That compares with $4.9M in the prior-year period — down 17.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCAD's other current liabilities is now $4M (was $4.9M) — a 17.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics is outperforming or lagging.

Tracking MCAD's other current liabilities over time shows whether Better Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $4M That compares with $4.9M in the prior-year period — down 17.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Better Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $4M) with ownership activity and broader fundamentals.